Topiramate IV for Neonatal Seizures
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Formulations and Indications
Phase Of Development
Phase 1
Sponsors and Collaborators
University of Minnesota; Ligang Pharmaceuticals (formerly CyDex), EF
Mechanism of Action
Mechanism Description
Toprimate IV
Populations Tested In
Neonatal seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2009
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link